Tadlas, Mary Joy .
HRN: 10-78-23 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2023
CEFUROXIME 500MG (TAB)
08/23/2023
08/30/2023
PO
500mg
BID
NSVD W/ RMLE
Waiting Final Action